scispace - formally typeset
D

David Bergqvist

Researcher at Uppsala University

Publications -  120
Citations -  14437

David Bergqvist is an academic researcher from Uppsala University. The author has contributed to research in topics: Low molecular weight heparin & Heparin. The author has an hindex of 40, co-authored 120 publications receiving 13694 citations. Previous affiliations of David Bergqvist include Uppsala University Hospital & Lund University.

Papers
More filters
Journal ArticleDOI

Surgical Renovascular Reconstruction for Renal Artery Stenosis and Aneurysm: Long-Term Durability and Survival.

TL;DR: Open surgical renal arterial reconstruction was performed with low mortality, fairly low morbidity, and excellent durability, and open surgery should still be considered a therapeutic option in complex renal artery disease.
Journal ArticleDOI

Activated coagulation in patients with shock due to ruptured abdominal aortic aneurysm.

TL;DR: The present data indicate a state of activated coagulation in patients with ruptured abdominal aortic aneurysm which is reinforced by shock.
Journal ArticleDOI

Iatrogenic Vascular Injuries With Lethal Outcome

TL;DR: Interventional radiology, general surgery, and cardiology are the main specialities involved in IVIs with lethal outcome, and almost half of the injuries were considered avoidable.
Journal ArticleDOI

Venous function in the leg after postoperative thrombosis diagnosed with 125I-fibrinogen uptake test.

TL;DR: In 179 patients who had been studied after operation with FUT, a follow-up evaluation of FUT as an indicator of risk for development of deep venous insufficiency was made four to five years later, and no statistically significant differences were found in any of the parameters between legs that had been FUT-positive and those that were F UT-negative at the time of the operation.
Journal ArticleDOI

Local complications of ascending phlebography.

TL;DR: A hypothesis is brought forward that skin necrosis with slow healing could be secondary to arterial thrombosis caused by extravasal contrast injection, which is high enough to warrant attention to the risks of the method.